| Date Filed | Type | Description |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2023 |
4
| Ballaron Craig (Director) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Granted 10,384 options to buy
@ $5.7, valued at
$59.2k
|
|
| 06/12/2023 |
4
| Eichenfield Lawrence (Director) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Granted 10,384 options to buy
@ $5.7, valued at
$59.2k
|
|
| 06/12/2023 |
4
| Nguyen Diem (Director) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Granted 10,384 options to buy
@ $5.7, valued at
$59.2k
|
|
| 06/12/2023 |
4
| PRYGOCKI MARK A SR (Director) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Granted 10,384 options to buy
@ $5.7, valued at
$59.2k
|
|
| 07/11/2022 |
4
| Hayes Christopher G. (Chief Legal Officer) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Bought 7,500 shares
@ $3.4, valued at
$25.5k
|
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Hayes Christopher G. (Chief Legal Officer) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Bought 5,714 shares
@ $2.1, valued at
$12k
|
|
| 07/05/2022 |
4
| White Ted (President and CEO) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Bought 23,809 shares
@ $2.1, valued at
$50k
|
|
| 07/05/2022 |
4
| Goldenberg Gary (Chief Medical Officer) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Bought 23,809 shares
@ $2.1, valued at
$50k
|
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Hayes Christopher G. (Chief Legal Officer) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Granted 75,000 options to buy
@ $8, valued at
$600k
|
|
| 02/25/2022 |
4
| Goldenberg Gary (Chief Medical Officer) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Granted 75,000 options to buy
@ $8, valued at
$600k
|
|
| 02/25/2022 |
4
| Kohler Terry (CFO) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Granted 75,000 options to buy
@ $8, valued at
$600k
|
|
| 02/25/2022 |
4
| Bonaccorso Joe (Chief Commercial Officer) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Granted 75,000 options to buy
@ $8, valued at
$600k
|
|
| 02/25/2022 |
4
| White Ted (President and CEO) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Granted 200,000 options to buy
@ $8, valued at
$1.6M
|
|
| 12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2021 |
4
| Kohler Terry (CFO) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Granted 125,000 options to buy
@ $10.28, valued at
$1.3M
|
|
| 07/20/2021 |
3
| Kohler Terry (CFO) has filed a Form 3 on Verrica Pharmaceuticals Inc. |
| 06/17/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/17/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/17/2021 |
4/A
| Ballaron Craig (Director) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Granted 8,109 options to buy
@ $10.56, valued at
$85.6k
|
|
| 06/17/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/14/2021 |
4
| Ballaron Craig (Director) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Granted 5,834 options to buy
@ $10.56, valued at
$61.6k
|
|
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|